
|Articles|October 10, 2018
FDA Renews and Expands its Use of Certara Software
Advertisement
Certara, a provider of drug development, regulatory science, market access, and real-world evidence solutions, announced that the US Food and Drug Administration has renewed its number of Certara software licenses such as Certara Phoenix, Simcyp, and Synchrogenix GlobalSubmit, for reviewing new drug and biologics applications. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
2
Redefining CRA Workflows Through Intelligent Automation
3
Applied Clinical Trials' 2025 State of the Industry Survey
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5